Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors

医学 内科学 冠状动脉粥样硬化 索引(排版) 风险因素 心脏病学 冠心病 计算机科学 万维网
作者
Ki‐Bum Won,Ran Heo,Hyung‐Bok Park,Byoung Kwon Lee,Fay Y. Lin,Martin Hadamitzky,Yong‐Jin Kim,Ji Min Sung,Edoardo Conte,Daniele Andreini,Gianluca Pontone,Matthew J. Budoff,Ilan Gottlieb,Eun Ju Chun,Filippo Cademartiri,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Jonathon Leipsic,Sang‐Eun Lee,Sanghoon Shin,Jung Hyun Choi,Renu Virmani,Habib Samady,Kavitha M. Chinnaiyan,Daniel S. Berman,Jagat Narula,Leslee J. Shaw,Jeroen J. Bax,James K. Min,Hyuk‐Jae Chang
出处
期刊:Atherosclerosis [Elsevier]
卷期号:324: 46-51 被引量:68
标识
DOI:10.1016/j.atherosclerosis.2021.03.009
摘要

The atherogenic index of plasma (AIP) has been suggested as a marker of plasma atherogenicity. This study aimed to assess the association between AIP and the rapid progression of coronary atherosclerosis using serial coronary computed tomography angiography (CCTA).A total of 1488 adults (60.9 ± 9.2 years, 58.9% male) who underwent serial CCTA with a median inter-scan period of 3.4 years were included. AIP was defined as the base 10 logarithm of the ratio of the concentrations of triglyceride to high-density lipoprotein cholesterol. Rapid plaque progression (RPP) was defined as the change of percentage atheroma volume (PAV) ≥1.0%/year. All participants were divided into three groups based on AIP tertiles.Baseline total PAV (median [interquartile range (IQR)]) (%) (group I [lowest]: 1.91 [0.00, 6.21] vs. group II: 2.82 [0.27, 8.83] vs. group III [highest]: 2.70 [0.41, 7.50]), the annual change of total PAV (median [IQR]) (%/year) (group I: 0.27 [0.00, 0.81] vs. group II: 0.37 [0.04, 1.11] vs. group III: 0.45 [0.06, 1.25]), and the incidence of RPP (group I: 19.7% vs. group II: 27.3% vs. group III: 31.4%) were significantly different among AIP tertiles (all p < 0.05). In multiple logistic regression analysis, the risk of RPP was increased in group III (odds ratio: 1.52, 95% confidence interval: 1.02-2.26; p = 0.042) compared to group I after adjusting for clinical factors and baseline total PAV.Based on serial CCTA findings, AIP is an independent predictive marker for RPP beyond traditional risk factors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
Ava应助清爽老九采纳,获得30
2秒前
3秒前
3秒前
大糖糕僧发布了新的文献求助10
3秒前
等待的小鸽子完成签到,获得积分10
5秒前
蟹蟹完成签到,获得积分10
5秒前
7秒前
7秒前
李爱国应助春风过客采纳,获得10
8秒前
韦雪莲发布了新的文献求助10
8秒前
花玥鹿完成签到,获得积分10
8秒前
626完成签到,获得积分20
9秒前
huang96应助eternity136采纳,获得20
11秒前
12秒前
13秒前
14秒前
Verdigris完成签到,获得积分10
15秒前
15秒前
sunlight完成签到,获得积分10
15秒前
聪明的金针菇完成签到,获得积分20
18秒前
CipherSage应助wuke采纳,获得30
19秒前
樱桃猴子应助棉花采纳,获得10
21秒前
22秒前
爱撒娇的大白菜真实的钥匙完成签到 ,获得积分10
22秒前
22秒前
隐形曼青应助俏皮麦片采纳,获得10
23秒前
酷酷访彤完成签到,获得积分10
23秒前
西瓜汁与菠萝汁完成签到,获得积分10
23秒前
25秒前
25秒前
zgt01完成签到,获得积分10
25秒前
25秒前
科研通AI2S应助眼睛大一点采纳,获得10
26秒前
26秒前
8R60d8应助Kervaff采纳,获得10
27秒前
28秒前
夏伊发布了新的文献求助10
28秒前
29秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
錢鍾書楊絳親友書札 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3297339
求助须知:如何正确求助?哪些是违规求助? 2932768
关于积分的说明 8459060
捐赠科研通 2605549
什么是DOI,文献DOI怎么找? 1422392
科研通“疑难数据库(出版商)”最低求助积分说明 661383
邀请新用户注册赠送积分活动 644677